From: Stock Gumshoe<travis@stockgumshoe.com>
Subject: What's Emerging Growth teasing for "Five Times Your Money?"
Preheader: Checking on a recent teaser pitch from Louis Navellier
Reply: travis@stockgumshoe.com
You're receiving this email newsletter because you, or someone
using newsletter@newslettercollector.com, signed up for the Stock Gumshoe Daily Update
 
Please unsubscribe if you don't want Stock Gumshoe emails
(this will not cancel membership, just stop emails). 

DAILY UPDATE
February 12, 2018
email formatted funny? Web version
Dear Valued Reader,

Louis Navellier has been promoting a "stock that stops cancer" of late in ads for his Emerging Growth newsletter -- I feel pretty safe in saying that we're all anti-cancer, so what is this stock... and does it really have a chance to make you "five times your money?"  I can at least get you some Thinkolator answers for the first part of that question... just click below to...


With individual stock selection now more critical than ever, this report is designed to bring you some of our top ideas for the year ahead.

One of the companies highlighted in this report controls the smartphone market and now has its sights set on owning a bigger technology.

It has the potential to be the most valuable stock in the history of investing. You need to find out the name of this company before the rest of the market does.

This Report Is Completely Free. Download Your Copy Today.


Advertisement

Miss anything last week?

We've gotten tons of questions about Matt Badiali's recent pitch for "Freedom Checks," with that tantalizing video showing him holding an official-looking check to tempt new subscribers...  So what are these big ol' fancy-looking checks that they're hinting about?  I looked into "Freedom Checks" for you here.

Christian DeHaemer spent a little time flinging mud in Elon Musk's eye and saying you should "buy this $10 EV company instead" of investing in his Tesla Motors.  Apparenlty this little company is half Tesla's size but is already profitable... so what's the story being pitched by Bubble and Bust?  Just click here for the details.

James Altucher is pitching his microcap newsletter with a promise of a "Windfall Profit Opportunity" next week as a little biotech gets the nod from the FDA... what's the story?  Just a click away, dear friend.

And Steve Sjuggerud offers up his prediction of the "next Tencent" from a different part of the world -- what's that next "ecosystem" tech company?  Just click here for the Thinkolator results.

I closed things out with a two-parter for the Irregulars -- part one of the Friday File included some big picture thoughts after a volatile week, and part two continued my Annual Review of the Real Money Portfolio (almost done, finally!)


IRREGULARS CORNER

Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Unsubscribe
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060